Dose-sparing effect of two adjuvant formulations with a pandemic influenza A/H7N9 vaccine: a randomized, double-blind, placebo-controlled, phase 1 clinical trial (2022)
- Authors:
- USP affiliated authors: KALLAS, ESPER GEORGES - FM ; COELHO, EDUARDO BARBOSA - FMRP ; CAMPOS, LÚCIA MARIA MATTEI DE ARRUDA - FM
- Unidades: FM; FMRP
- DOI: 10.1371/journal.pone.0274943
- Subjects: INFLUENZA; VÍRUS; VACINAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: San Francisco
- Date published: 2022
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
VANNI, Tazio et al. Dose-sparing effect of two adjuvant formulations with a pandemic influenza A/H7N9 vaccine: a randomized, double-blind, placebo-controlled, phase 1 clinical trial. Plos one, v. 17, n. 10, 2022Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0274943. Acesso em: 28 fev. 2026. -
APA
Vanni, T., Thomé, B. C., Sparrow, E., Friede, M., Fox, C. B., Beckmann, A. M., et al. (2022). Dose-sparing effect of two adjuvant formulations with a pandemic influenza A/H7N9 vaccine: a randomized, double-blind, placebo-controlled, phase 1 clinical trial. Plos one, 17( 10). doi:10.1371/journal.pone.0274943 -
NLM
Vanni T, Thomé BC, Sparrow E, Friede M, Fox CB, Beckmann AM, Huynh C, Mondini G, Silveira DH, Kallas EG, Coelho EB, Campos LMM de A. Dose-sparing effect of two adjuvant formulations with a pandemic influenza A/H7N9 vaccine: a randomized, double-blind, placebo-controlled, phase 1 clinical trial [Internet]. Plos one. 2022 ; 17( 10):[citado 2026 fev. 28 ] Available from: https://doi.org/10.1371/journal.pone.0274943 -
Vancouver
Vanni T, Thomé BC, Sparrow E, Friede M, Fox CB, Beckmann AM, Huynh C, Mondini G, Silveira DH, Kallas EG, Coelho EB, Campos LMM de A. Dose-sparing effect of two adjuvant formulations with a pandemic influenza A/H7N9 vaccine: a randomized, double-blind, placebo-controlled, phase 1 clinical trial [Internet]. Plos one. 2022 ; 17( 10):[citado 2026 fev. 28 ] Available from: https://doi.org/10.1371/journal.pone.0274943 - Anticorpos antinucleossomo em paciente com lúpus eritematoso sistêmico juvenil
- No Evidence of Sexual Risk Compensation in the iPrEx Trial of Daily Oral HIV Preexposure Prophylaxis
- Subsets of Memory CD4+ T Cell and Bactericidal Antibody Response to Neisseria meningitidis Serogroup C after Immunization of HIV-Infected Children and Adolescents
- Viral infections and implications for male reproductive health
- Global Assessment of Dengue Virus-Specific CD4+ T Cell Responses in Dengue-Endemic Areas
- Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance
- Antigenic competition in CD4(+) T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial
- Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository
- Imbalanced expression of functional surface molecules in regulatory and effector T cells in systemic lupus erythematosus
- Latent Mycobacterium tuberculosis Infection Is Associated With a Higher Frequency of Mucosal-Associated Invariant T and Invariant Natural Killer T Cells
Informações sobre o DOI: 10.1371/journal.pone.0274943 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003270591.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
